{"id":"W150401912","doi":"10.3833/pdr.v2011i6.1485","title":"Boehringer Ingelheim Licenses Zealand Pharma’s Drug Candidates for Type 2 Diabetes and Obesity","year":2011,"lang":"en","type":"article","venue":"PharmaDeals Review","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Milestone; Type 2 diabetes; Payment; Obesity; Quarter (Canadian coin); Business; Diabetes mellitus; Internal medicine; Finance; Endocrinology; Geography","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004153655,0.0002471634,0.0006403615,0.00005804425,0.0001283473,0.000008584484,0.00009495801,0.00004943004,0.0008761882],"category_scores_gemma":[0.00007672461,0.0001897257,0.0001130404,0.000127634,0.00008269593,0.0001207175,0.00005822555,0.0001653657,0.000112025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003671734,"about_ca_system_score_gemma":0.00006172236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000025323,"about_ca_topic_score_gemma":0.000004115886,"domain_scores_codex":[0.9987713,0.0000895239,0.0003142387,0.0003311448,0.0001104037,0.0003834529],"domain_scores_gemma":[0.9991663,0.0001345953,0.0001233482,0.000177313,0.0001171578,0.0002813552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007801456,0.001842387,0.5823645,0.02288611,0.00179304,0.0001381849,0.00171898,8.24894e-8,0.009648404,0.000103451,0.3429261,0.03579867],"study_design_scores_gemma":[0.008326405,0.0007671262,0.09135862,0.006354763,0.008431867,0.000161861,0.0000280749,0.00008441479,0.1758341,0.0003534386,0.7074061,0.0008932407],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.644533,0.3512621,0.000002034334,0.001377181,0.0002324086,0.001470615,0.00003269949,0.00009295723,0.0009970007],"genre_scores_gemma":[0.6315562,0.3558418,0.0005311669,0.01026481,0.0001851231,0.0002131738,0.00006512435,0.00003341663,0.001309184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4910059,"threshold_uncertainty_score":0.9593647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08240199183654418,"score_gpt":0.3650932836274937,"score_spread":0.2826912917909495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}